According to Myovant Sciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.9216. At the end of 2022 the company had a P/S ratio of 6.88.
Year | P/S ratio | Change |
---|---|---|
2022 | 6.88 | -6.53% |
2021 | 7.36 | -89.78% |
2020 | 72.1 | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |